I think one of the things is that universities, particularly smaller universities, are so busy chasing undergraduate enrolment that they are then not able to put funding into basic research. I think that's one of the problems.
I think there are a lot of universities where there are not commercialization enterprises going on. I come back to the comment that was made earlier about basically making sure that you have the resources to be able to run through the process of taking an invention all the way to discovery and commercialization.
Another thing that I think is important is the development of a philanthropic dimension, which is perhaps the other one that you've talked about. In the last few months for a variety of reasons, I've had interactions with the Broad Institute—which I'm sure some of my colleagues are aware of, if not the rest of you. This is a joint venture through Harvard and MIT that was funded in part by the Broad family. They have a number of missions, if you will. I have them listed here. Each one has two words essentially: act nimbly, work boldly, share openly, and reach globally. Those are the criteria through which Eli and Edythe Broad mandated the growth of this institution, which is working on an enormous range of biomedical applications.
I'll leave it at that.